Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REGISTERED PLAN PRIVATE INVESTMENTS INC.

(LXGTF)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Lexington Biosciences, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020

11/30/2020 EST

Lexington Biosciences, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced net loss was CAD 45,210 compared to CAD 101,025 a year ago. Basic eps - continuing operations was CAD 0 compared to CAD 0.03 a year ago. For the nine months, net loss was CAD 389,801 compared to CAD 431,350 a year ago. Basic earnings per share from continuing operations was CAD 0.06 compared to CAD 0.11 a year ago.


ę S&P Capital IQ 2020
All news about REGISTERED PLAN PRIVATE INVESTMENTS INC.
08/30Registered Plan Private Investments Inc. Reports Earnings Results for the Second Quarte..
CI
05/31Registered Plan Private Investments Inc. Reports Earnings Results for the First Quarter..
CI
04/30Lexington Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 3..
CI
2020Lexington Biosciences, Inc. Reports Earnings Results for the Third Quarter Ended Septem..
CI
2020Lexington Biosciences, Inc. Reports Earnings Results for the Second Quarter Ended June ..
CI
2020Lexington Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March ..
CI
2020Lexington Biosciences, Inc. Approves the Election of Tamara Manuel as Director
CI
2020Lexington Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 3..
CI
2020Lexington Biosciences, Inc. Announces Executive Changes
CI
2020Lexington Biosciences, Inc. announced that it expects to receive CAD 0.5 million in fun..
CI
More news
Financials
Sales 2020 - - -
Net income 2020 -0,48 M -0,38 M -0,38 M
Net cash 2020 0,03 M 0,02 M 0,02 M
P/E ratio 2020 -4,75x
Yield 2020 -
Capitalization 0,07 M 0,05 M 0,05 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees -
Free-Float 13,6%
Chart REGISTERED PLAN PRIVATE INVESTMENTS INC.
Duration : Period :
Registered Plan Private Investments Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Donald Arthur McInnes Chief Executive Officer
Nicholas Furber Chief Financial Officer
Douglas Glen Janzen Chairman
Bryan Disher Independent Director
Tamara Manuel Director
Sector and Competitors
1st jan.Capi. (M$)
REGISTERED PLAN PRIVATE INVESTMENTS INC.-97.59%0
ABBOTT LABORATORIES16.93%226 394
MEDTRONIC PLC-5.86%148 311
BECTON, DICKINSON AND COMPANY-2.64%69 191
HOYA CORPORATION26.28%58 287
DEXCOM, INC.54.44%55 343